Evidence map›Paper›PMID 19578481›Full record

ArticleBreast cancer : basic and clinical research2008

Cost-effective screening for breast cancer worldwide: current state and future directions.

A Sarvazyan, V Egorov, J S Son, C S Kaufman

3 registry-linked trialsAbstract read
In one paragraph

Article in Breast cancer : basic and clinical research, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 3 registered trials, which are not on this map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04397029 naterminatednot on this mapstarted 2019, after this paper: background citation

Assessing the Sensitivity of "SureTouch™" in Identifying Clinically Significant Masses in Women Undergoing Diagnostic and Screening Mammography

TypeinterventionalSponsorGeorge Washington UniversityRan2019 to 2021Enrolled213ConditionsBreast CancerArmsSureTouch
NCT05882019 naunknown statusnot on this mapstarted 2023, after this paper: background citation

Evaluation of the "Bexa™" Breast Examination (BBE) as an Effective Solution to Breast Cancer Early Detection

TypeinterventionalSponsorSure, Inc.Ran2023 to 2023Enrolled700ConditionsBreast CancerArmsBreast Exam with Bexa
NCT06643767 narecruitingnot on this mapstarted 2024, after this paper: background citation

Evaluation of the Bexa Breast Examination (BBE) as an Effective Solution to Breast Cancer Early Detection

TypeinterventionalSponsorSure, Inc.Ran2024 to 2025Enrolled500ConditionsBreast CancerArmsBexa and focus ultrasound
3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Article
  4. Vaginal tactile imaging: A review.Pelviperineology · 2023
    Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

A SarvazyanArtann Laboratories, 1459 Lower Ferry Rd., Trenton, NJ 08618, U.S.A.
V Egorov
J S Son
C S Kaufman

Funding

IMAGING NETWORK FOR BREAST CANCER MASS SCREENINGR44CA091392 · NCI · ARTANN LABORATORIES, INC. · PI SARVAZYAN, ARMEN · 2004 to 2007
$2.2M
IMAGING NETWORK FOR BREAST CANCER MASS SCREENINGR43CA091392 · NCI · ARTANN LABORATORIES, INC. · PI SARVAZYAN, ARMEN · 2001 to 2001
$146k
USE OF A TACTILE BREAST IMAGER FOR MASS PRE-SCREENINGR43CA094444 · NCI · ARTANN LABORATORIES, INC. · PI SARVAZYAN, ARMEN · 2002 to 2002
$131k
NCI NIH HHS R43 CA091392NCI NIH HHS R43 CA094444NCI NIH HHS R44 CA091392
6 · The paper itself

Abstract

Affordability of healthcare is highly limited by its skyrocketing cost. Access to screening and diagnostic medical equipment and medicine in developing countries is inadequate for the majority of the population. There is a tremendous worldwide need to detect breast cancer at its earliest stage. These needs must be balanced by the ability of countries to provide breast cancer screening technology to their populations. We reviewed the diagnostic accuracy, procedure cost and cost-effectiveness of currently available technique for breast screening and diagnosis including clinical breast examination, mammography, ultrasound, magnetic resonance imaging, biopsy and a new modality for cancer diagnostics termed elasticity imaging that has emerged in the last decade. Clinical results demonstrate that elasticity imaging even in its simplest and least sophisticated versions, like tactile imaging, has significant diagnostic potential comparable and exceeding that of conventional imaging techniques. In view of many countries with limited resources, effective yet less expensive modes of screening must be considered worldwide. The tactile imaging is one method that has the potential to provide cost-effective breast cancer screening and diagnostics.

Indexed as

breast cancercost-effectivenesselastographyscreening

Identifiers

PMID19578481
PMCPMC2613364

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.